Article
A New Labelling Method of <sup>99m</sup> Tc-PSMA-HBED-CC
2024-11-03
Abstract excerpt
<h4>Objective</h4> 68 Ga-PSMA-HBED-CC ( 68 Ga-PSMA-11) was approved by the US FDA as the first PSMA-targeted PET imaging drug for patients with prostate cancer. However, the utility of 68 Ga-PSMA-HBED-CC may be limited due to PET/CT or PET/MR accessibility and 68 GaCl 3 availability produced from 68 Ge/ 68 Ga generator or cyclotron. Thus, in-house preparation of 99m Tc-PSMA-HBED-CC was developed as an alte...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9ae77bdb-64d3-56ad-94ed-e41acdef7a3a
- DOI
- 10.1101/2024.10.31.621442
